University of Nottingham Repository
metadata only
Studies of titanium-based anti-cancer agents and their effects on cancer cell lines
Cancer is a leading cause of mortality worldwide, and there is an urgent need for development of new therapies. Pancreatic ductal adenocarcinoma (PDAC), on the other hand, is the most aggressive types of cancers, with 90% of pancreatic cancer cases worldwide. In most cancers, especially pancreatic c
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery#311194
- Irinotecan Liposome in Combination With Capecitabine#1164336
- QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC#850678
- QUILT-3.088: NANT Pancreatic Cancer Vaccine#127662
- QUILT-3.080: NANT Pancreatic Cancer Vaccine#238170
Record · ID 1055563
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive